Atara Biotherapeutics
ATRA
ATRA
148 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 44 reducing their positions, and 20 closing their positions.
Holders
148
Holders Change
+8
Holders Change %
+5.71%
% of All Funds
2.63%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
59
Reduced
44
Closed
20
Calls
$1.76M
Puts
$1.82M
Net Calls
-$59K
Net Calls Change
-$1.04M
Top Buyers
1 |
1
Morgan Stanley
New York
|
$71.2M |
2 |
KXA
2
KPCB XV Associates
Menlo Park,
California
|
$36.8M |
3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$22.1M |
4 |
4
Citigroup
New York
|
$24.8M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$111M |